PGMN3 logo

Empreendimentos Pague Menos Stock Price

Symbol: BOVESPA:PGMN3Market Cap: R$2.4bCategory: Consumer Retailing

PGMN3 Share Price Performance

Recent PGMN3 News & Updates

No updates

Empreendimentos Pague Menos S.A. Key Details

R$13.1b

Revenue

R$9.0b

Cost of Revenue

R$4.2b

Gross Profit

R$4.1b

Other Expenses

R$41.9m

Earnings

Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 04, 2025
Earnings per share (EPS)
0.068
Gross Margin
31.71%
Net Profit Margin
0.32%
Debt/Equity Ratio
51.7%

Empreendimentos Pague Menos S.A. Competitors

 
 
 
 
 
 
 
 
 
 
 
 

About PGMN3

Founded
1981
Employees
26261
CEO
Jonas Neto
WebsiteView website
www.paguemenos.com.br

Empreendimentos Pague Menos S.A. operates a chain of pharmacies in Brazil. The company offers medicines and health care products in the areas of paediatrics, oncology, psychiatry, urology, orthopedics, dermatology, contraception, pediatric endocrinology, assisted reproduction, geriatric, gastrointestinal and hepatic, pain, fever, and inflammation, diabetes, and endocrinology. It also provides personal care and beauty products, including deodorant, intimate care, and oral hygiene, as well as foot, hair, face, and hand care products; dermo-cosmetics; and repellent, diaper, cloth, and food products, as well as other accessories for moms and babies. In addition, the company offers clothing and accessories, supplements, first aid, food and drink, utilities, and others; and cereals, fibers, vitamins and minerals, first aid, and herbal medicines and natural products. Empreendimentos Pague Menos S.A. was incorporated in 1981 and is headquartered in Fortaleza, Brazil.

Brazilian Market Performance

  • 7 Days: -0.9%
  • 3 Months: -3.1%
  • 1 Year: -2.0%
  • Year to Date: 6.2%
Over the last 7 days, the market has remained flat, although notably the Consumer Staples sector declined by 6.2%. As for the longer term, the market has also been flat over the past year. Earnings are forecast to grow by 14% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading